Literature DB >> 29795747

Allosteric Modulation of Ionotropic Glutamate Receptors Special Issue.

Nicholas I Carruthers1, Timothy W Lovenberg1, Stephen F Traynelis2.   

Abstract

Call for papers! ACS Medicinal Chemistry Letters is now accepting manuscript submissions for a special issue entitled "Allosteric Modulation of Ionotropic Glutamate Receptors". This special issue is a cross-thematic issue with Journal of Medicinal Chemistry and ACS Chemical Neuroscience. The ACS Medicinal Chemistry Letters special issue is scheduled for publication in early 2019.

Year:  2018        PMID： 29795747      PMCID： PMC5949834          DOI： 10.1021/acsmedchemlett.8b00174

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


  4 in total

1.  Context-dependent GluN2B-selective inhibitors of NMDA receptor function are neuroprotective with minimal side effects.

Authors:  Hongjie Yuan; Scott J Myers; Gordon Wells; Katherine L Nicholson; Sharon A Swanger; Polina Lyuboslavsky; Yesim A Tahirovic; David S Menaldino; Thota Ganesh; Lawrence J Wilson; Dennis C Liotta; James P Snyder; Stephen F Traynelis
Journal:  Neuron       Date:  2015-02-26       Impact factor: 17.173

Review 2.  New advances in NMDA receptor pharmacology.

Authors:  Kevin K Ogden; Stephen F Traynelis
Journal:  Trends Pharmacol Sci       Date:  2011-10-11       Impact factor: 14.819

Review 3.  Getting a Handle on Neuropharmacology by Targeting Receptor-Associated Proteins.

Authors:  Michael P Maher; Jose A Matta; Shenyan Gu; Mark Seierstad; David S Bredt
Journal:  Neuron       Date:  2017-12-06       Impact factor: 17.173

Review 4.  Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action.

Authors:  Erica S Burnell; Mark Irvine; Guangyu Fang; Kiran Sapkota; David E Jane; Daniel T Monaghan
Journal:  J Med Chem       Date:  2018-03-05       Impact factor: 7.446
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.